In particular, several studies conducted on metastatic melanoma patients have highlighted the utility of liquid biopsy in detecting and monitoring BRAF/NRAS mutations through the use of different technologies [10,11,12,13,14,15,16,17]. Here, NRAS is linked to metastatic melanoma.